Di Maio, Massimo <br/><br/>
Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer.  [electronic resource] 

 -  Expert opinion on biological therapy  Sep 2011 
 - 1131-3 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.2011.599799  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials as Topic<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Prognosis